A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging

Andrew F. Voter, Rudolf A. Werner, Hatice Savas, Andrei Gafita, Ashley E. Ross, Michael A. Gorin, Lilja B. Solnes, Martin G. Pomper, Steven P. Rowe, Sara Sheikhbahaei

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Prostate-specific membrane antigen (PSMA)-targeted PET agents have revolutionized the care of patients with prostate cancer, supplanting traditional methods of imaging prostate cancer, and improving the selection and delivery of therapies. This has led to a rapid expansion in both the number of PSMA PET scans performed and the imaging specialists required to interpret those scans. To aid those imagers and clinicians who are new to the interpretation of PSMA PET, this review provides an overview of the interpretation of PSMA PET/CT imaging and pearls for overcoming commonly encountered pitfalls. We discuss the physiologic distribution of the clinically available PSMA-targeted radiotracers, the commonly encountered patterns of prostate cancer spread, as well as the benign and malignant mimics of prostate cancer. Additionally, we review the standardized PSMA PET reporting systems and the role of PSMA in selecting appropriate patients for PSMA-targeted therapies.

Original languageEnglish
Pages (from-to)119-131
Number of pages13
JournalSeminars in Nuclear Medicine
Issue number1
StatePublished - Jan 2024


Dive into the research topics of 'A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging'. Together they form a unique fingerprint.

Cite this